ELEVATE study

Not Applicable

Recruiting

• Conditions: oropharynx cancer or hypopharynx cancer; head and neck cancer, opharynx cancer, hypopharynx cancer; D006258

• Registration Number: JPRN-jRCTs052220011
• Lead Sponsor: emura Hirokazu

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-04-22
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

1. Patients with oropharynx or hypopharynx cancer (regardless of tissue system) who undergo chemoradiation treatment or radiation treatment as the first curative treatment. But, patients who have undergone chemotherapy prior to chemoradiation treatment or radiation treatment are included.
2. Age: 18 to 85 years old
3. Performance Status (ECOG) is 0 or 1 (within one month prior to obtaining consent)
4. Patients with written consent for participation of this clinical study from the patient or its representative

Exclusion Criteria

1. Patients whose don't recognize measurer's instructions (e.g. patients with dementia, aphasia, aphasia, higher brain dysfunction, intellectually disabled, etc.)
2. Patients who can't grip the tongue pressure probe with the front teeth (e.g. patients who are toothless jaws and are not wearing dentures)
3. Patients who can't crush the tongue pressure probe (e.., patients who cannot move the tongue at all)
4. Patients with dysphagia du to the pretreatment for head and neck cancer
5. Patients with significant decrease in swallowing function due to a history of central diseases, etc.
6. Other patients who are judged inadequate to this research by the principal (sub) investigator

Study & Design

• Study Type: Interventional
• Study Design: Not specified